Trial NCT05046548
Publication Ishmukhametov AA, medRxiv, 2022
Primary outcome on the report: 1) frequency and severity of AEs within the observation period (72 h, 7 days after each vaccination and 28 days after the 2nd vaccination); 2) the geometric mean nAB titer (GMT) and seroconversion rate (the percentage of volunteers with 4-fold increase in GMT) 28 days after the 2nd vaccination

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.